ArticleInternational journal of antimicrobial agents2021

Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial.

Guoming Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.